EML 425 is a non-competitive inhibitor of the lysine acetyltransferase type 3 (KAT3) histone acetyltransferase p300 and CREB-binding protein (CBP; IC50s = 2.9 and 1.1 ?M, respectively).1 It prevents glucose-induced cataract formation in isolated rat lens when used at a concentration of 200 ?M.2
1.Milite, C., Feoli, A., Sasaki, K., et al.A novel cell-permeable, selective, and noncompetitive inhibitor of KAT3 histone acetyltransferases from a combined molecular pruning/classical isosterism approachJ. Med. Chem.58(6)2779-2798(2015) 2.Kanada, F., Takamura, Y., Miyake, S., et al.Histone acetyltransferase and Polo-like kinase 3 inhibitors prevent rat galactose-induced cataractSci. Rep.9(1)20085(2019)
















